SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-238857
Filing Date
2022-09-06
Accepted
2022-09-06 16:15:40
Documents
14
Period of Report
2022-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d385461d8k.htm   iXBRL 8-K 31911
2 EX-10.1 d385461dex101.htm EX-10.1 113222
3 EX-99.1 d385461dex991.htm EX-99.1 10670
  Complete submission text file 0001193125-22-238857.txt   315144

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amrx-20220901.xsd EX-101.SCH 2853
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrx-20220901_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrx-20220901_pre.xml EX-101.PRE 10810
8 EXTRACTED XBRL INSTANCE DOCUMENT d385461d8k_htm.xml XML 3239
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 221228425
SIC: 2834 Pharmaceutical Preparations